Dados B3 › CGAS5 × EGIE3
CGAS5 × EGIE3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | CGAS5 | EGIE3 | year |
|---|---|---|---|
| ROE | 120.1%! | 21.5% | 2025 |
| ROIC | 23.9% | 13.9% | 2025 |
| ROA | 10.1% | 5.4% | 2025 |
| Gross margin | 30.2% | 46.7% | 2025 |
| EBIT margin | 25.8% | 48.7% | 2025 |
| Net margin | 13.3% | 22.2% | 2025 |
| Net debt/EBITDA | 2.25x | 3.30x | 2025 |
| Current ratio | 1.53x | 1.12x | 2025 |
| Revenue growth (1y) | -25.0% | 14.6% | 2025 |
| Revenue growth (5y CAGR) | 6.9% | 1.0% | 2025 |
| Piotroski F-Score | 6/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | CGAS5 | EGIE3 | year |
|---|---|---|---|
| P/E | 11.29x | 14.21x | 2025 |
| P/B | 12.11x | 2.88x | 2025 |
| EV/EBITDA | 7.00x | 8.09x | 2025 |
| FCF yield | — | 4.3% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:15 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:15 UTC. If this does not match /saude, you are reading a cached copy.